Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Cover

Depression: From Psychopathology to Pharmacotherapy

Cryan J.F. (Cork) 
Leonard B.E. (Galway) 

Status: available   
Publication year: 2010
Buy this book
Digital Version: CHF 148.00, EUR 138.00, USD 174.00
Print Version: CHF 148.00, EUR 138.00, USD 174.00
The final prices may differ from the prices shown due to specifics of VAT rules, postage and handling.
Order this title

You already have online access to this title. If you would like to buy a personal digital or print copy, please click here.


This book belongs to
Modern Trends in Pharmacopsychiatry , Vol. 27
Editor(s): Leonard B.E. (Galway) 
VIII + 274 p., 11 fig., 13 tab., hard cover, 2010
Status: available   
ISSN: 1662-2685
e-ISSN: 1662-4505

What’s new in antidepressant research?
Despite the availability of antidepressants for over 40 years, a substantial proportion of depressed patients do not respond adequately to treatment. Failure to respond effectively to treatment contributes to physical ill-health and psychiatric morbidity, often resulting in premature death of the depressed patient. The purpose of this volume is to consider the possible reasons for the limitations of the currently available antidepressants, to examine the advances in our understanding of the psychopathology of depression and how such knowledge may assist in the discovery of new methods of treatment. Leading international experts in this field discuss the possible underlying reasons for depression and limitations of current antidepressants. Opportunities for novel therapeutic approaches to dysfunctional circadian rhythms and mood disorders as well as current status and future perspectives for optimizing antidepressant management of depression are reviewed.

This publication illustrates the breadth of the latest research and is valuable reading for psychiatrists, neuroscientists and pharmacologists.